Trademarkia Logo

Canada

C$
REVUFORJ
REGISTERED

on 2 Apr 2025

Last Applicant/ Owned by

Syndax Pharmaceuticals, Inc.

35 Gatehouse Drive, Building D, Floor 3Waltham MA 02451

US

Serial Number

2274562 filed on 14th Jul 2023

Registration Number

TMA1304176 registered on 2th Apr 2025

Registration expiry Date

14th Jul 2033

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

CA

M5H3Y2

REVUFORJ

Trademark usage description

pharmaceutical preparations for the treatment of cancer. research and development of pharmaceuticals for the treatment of cancer; medical and scienti Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cancer.


Classification kind code

12

Class [042]
Research and development of pharmaceuticals for the treatment of cancer; medical and scientific research services in the field of cancer treatment.


Classification kind code

12

Class [044]
Providing information in the field of cancer treatment; providing links to the web sites of others featuring information about the diagnosis and treatment of cancer.


Classification kind code

12

Mark Details


Serial Number

2274562

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 27
on 17th Dec 2024
Approval Notice Sent
Submitted for opposition 26
on 17th Dec 2024
Approved
Submitted for opposition 22
on 9th Dec 2024
Search Recorded
Submitted for opposition 256
on 10th Jun 2024
Notification of Possible Opposition Sent
Submitted for opposition 48
on 25th Aug 2023
Agent Changed
Submitted for opposition 257
on 10th Aug 2023
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 9th Aug 2023
Formalized
Submitted for opposition 1
on 9th Aug 2023
Created
Submitted for opposition 30
on 14th Jul 2023
Filed
Submitted for opposition 228
on 14th Jul 2023
International Registration